Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Infections × Ciprofloxacin × Clear all

Phase

Phase 3 2 Phase 2/3 2 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2 Neoplasms 2 Febrile Neutropenia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pancreatic Cyst 1 Neutropenia 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Infections 1 Early Stage Breast Cancer 1 Cysts 1 Cystectomy 1 Breast Neoplasms 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 2 soybean oil, phospholipid emulsion 1 drotrecogin alfa activated 1 Vancomycin 1 Teicoplanin 1 Fosfomycin 1 Docosahexaenoic Acids 1 Clindamycin 1 ClinOleic 1 Ciprofloxacin 1 Cephalexin 1 Anti-Bacterial Agents 1 Amoxicillin-Potassium Clavulanate Combination 1 Amdinocillin Pivoxil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03228108 2022-05-10

pro-SWAP

Radboud University Medical Center

Phase 4 Completed

Infections, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡